サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1747082

日本のアプタマー市場レポート：タイプ、用途、地域別、2025～2033年

Japan Aptamers Market Report by Type (Nucleic Acid, Peptide), Application (Diagnostics, Therapeutics, Research and Developments, and Others), and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 119 Pages
納期
5～7営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.08円
日本のアプタマー市場レポート：タイプ、用途、地域別、2025～2033年
出版日: 2025年06月02日
発行: IMARC
ページ情報: 英文 119 Pages
納期: 5～7営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

日本のアプタマー市場規模は2024年に1億8,300万米ドルに達しました。今後、IMARC Groupは、同市場が2033年までに6億3,400万米ドルに達し、2025～2033年にかけて14.80%の成長率（CAGR）を示すと予測しています。革新的な診断・治療ソリューションに対する需要の高まり、バイオマーカーの検出における利用の増加、最先端のドラッグデリバリーシステムへの統合の進展などが、市場を牽引する主要因となっています。

本レポートで扱う主要質問

  • 日本のアプタマー市場はこれまでどのように推移し、今後どのように推移するのか？
  • COVID-19が日本のアプタマー市場に与えた影響は？
  • 日本のアプタマー市場のタイプ別区分は？
  • 日本のアプタマー市場の用途別区分は？
  • 日本のアプタマー市場のバリューチェーンにおける様々なステージとは？
  • 日本のアプタマーの主要な促進要因と課題は？
  • 日本のアプタマー市場の構造と主要参入企業は？
  • 日本のアプタマー市場における競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
  • 市場推定
  • 調査手法

第3章 エグゼクティブサマリー

第4章 日本のアプタマー市場-イントロダクション

  • 概要
  • 市場力学
  • 産業動向
  • 競合情報

第5章 日本のアプタマー市場情勢

  • 過去と現在の市場動向（2019～2024年）
  • 市場予測（2025～2033年）

第6章 日本のアプタマー市場-タイプ別内訳

  • 核酸
  • ペプチド

第7章 日本のアプタマー市場-用途別内訳

  • 診断
  • 治療
  • 研究開発
  • その他

第8章 日本のアプタマー市場-競合情勢

  • 概要
  • 市場構造
  • 市場企業のポジショニング
  • 主要成功戦略
  • 競合ダッシュボード
  • 企業評価象限

第9章 主要企業のプロファイル

第10章 日本のアプタマー市場-産業分析

  • 促進要因・抑制要因・機会
  • ポーターのファイブフォース分析
  • バリューチェーン分析

第11章 付録

目次
Product Code: SR112025A18954

Japan aptamers market size reached USD 183.0 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 634.0 Million by 2033, exhibiting a growth rate (CAGR) of 14.80% during 2025-2033. The rising demand for innovative diagnostic and therapeutic solutions, increasing utilization in detecting biomarkers, and the growing integration into cutting-edge drug delivery systems represent some of the key factors driving the market.

Aptamers, also known as chemical antibodies, are short, single-stranded deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) molecules that can selectively bind to specific target molecules, such as proteins, small molecules, and whole cells. They are artificially synthesized through the systematic evolution of ligands by exponential enrichment process. They are stable under a wide range of conditions, including extreme temperatures and pH levels, and contribute to their utility in diverse environments. They can be chemically synthesized with high purity, allowing for cost-effective production and customization. They generally have low immunogenicity, which reduces the likelihood of immune responses when used in biological applications. They provide precise targeting of specific molecules, enabling researchers to study and manipulate biological processes with optimal accuracy. They are widely used in diagnostic assays for detecting biomarkers associated with diseases, making them invaluable for early disease detection. Besides this, they find numerous applications in environmental monitoring to detect pollutants and contaminants.

Japan Aptamers Market Trends:

The escalating demand for innovative diagnostic and therapeutic solutions in Japan represents one of the key factors favoring the market growth. Additionally, the increasing utilization of aptamers in detecting biomarkers associated with diseases like cancer and infectious diseases is strengthening the growth of the market. Along with this, the presence of a robust pharmaceutical and biotechnology sector in Japan is contributing to the market growth. Apart from this, the integration of aptamers into cutting-edge drug delivery systems is supporting the market growth. Moreover, rising collaborations between academic institutions, biotech firms, and pharmaceutical giants are driving research and development (R&D) activities to harness the therapeutic potential of aptamers, further bolstering the market growth. Besides this, the regulatory support and streamlined approval processes for innovative biotechnological products is offering a favorable market outlook. Furthermore, the regulatory authorities in the country are actively working to facilitate the development and commercialization of biopharmaceuticals, including aptamer-based drugs. Besides this, the ongoing research into novel aptamer modifications and delivery mechanisms is positively influencing the market. Researchers are continually improving the stability, specificity, and pharmacokinetics of aptamers, making them even more effective as therapeutic and diagnostic tools. Additionally, Japan is witnessing a rise in the development of aptamer-based point-of-care (POC) diagnostic devices. These user-friendly, rapid-testing platforms leverage the specificity of aptamers to detect biomarkers or pathogens in clinical settings. Moreover, the expanding aging population in the country, which is highly susceptible to several chronic diseases, is facilitating the market growth. Leading universities and research institutions in Japan are actively engaged in aptamer-related studies, fostering a culture of innovation and knowledge exchange. This academic prowess contributes to the development of novel aptamers.

Japan Aptamers Market Segmentation:

Type Insights:

  • Nucleic Acid
  • Peptide

Application Insights:

  • Diagnostics
  • Therapeutics
  • Research and Developments
  • Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan aptamers market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan aptamers market?
  • What is the breakup of the Japan aptamers market on the basis of type?
  • What is the breakup of the Japan aptamers market on the basis of application?
  • What are the various stages in the value chain of the Japan aptamers market?
  • What are the key driving factors and challenges in the Japan aptamers?
  • What is the structure of the Japan aptamers market and who are the key players?
  • What is the degree of competition in the Japan aptamers market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Aptamers Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Aptamers Market Landscape

  • 5.1 Historical and Current Market Trends (2019-2024)
  • 5.2 Market Forecast (2025-2033)

6 Japan Aptamers Market - Breakup by Type

  • 6.1 Nucleic Acid
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2019-2024)
    • 6.1.3 Market Forecast (2025-2033)
  • 6.2 Peptide
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2019-2024)
    • 6.2.3 Market Forecast (2025-2033)

7 Japan Aptamers Market - Breakup by Application

  • 7.1 Diagnostics
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2019-2024)
    • 7.1.3 Market Forecast (2025-2033)
  • 7.2 Therapeutics
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2019-2024)
    • 7.2.3 Market Forecast (2025-2033)
  • 7.3 Research and Developments
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2019-2024)
    • 7.3.3 Market Forecast (2025-2033)
  • 7.4 Others
    • 7.4.1 Historical and Current Market Trends (2019-2024)
    • 7.4.2 Market Forecast (2025-2033)

8 Japan Aptamers Market - Competitive Landscape

  • 8.1 Overview
  • 8.2 Market Structure
  • 8.3 Market Player Positioning
  • 8.4 Top Winning Strategies
  • 8.5 Competitive Dashboard
  • 8.6 Company Evaluation Quadrant

9 Profiles of Key Players

  • 9.1 Company A
    • 9.1.1 Business Overview
    • 9.1.2 Product Portfolio
    • 9.1.3 Business Strategies
    • 9.1.4 SWOT Analysis
    • 9.1.5 Major News and Events
  • 9.2 Company B
    • 9.2.1 Business Overview
    • 9.2.2 Product Portfolio
    • 9.2.3 Business Strategies
    • 9.2.4 SWOT Analysis
    • 9.2.5 Major News and Events
  • 9.3 Company C
    • 9.3.1 Business Overview
    • 9.3.2 Product Portfolio
    • 9.3.3 Business Strategies
    • 9.3.4 SWOT Analysis
    • 9.3.5 Major News and Events
  • 9.4 Company D
    • 9.4.1 Business Overview
    • 9.4.2 Product Portfolio
    • 9.4.3 Business Strategies
    • 9.4.4 SWOT Analysis
    • 9.4.5 Major News and Events
  • 9.5 Company E
    • 9.5.1 Business Overview
    • 9.5.2 Product Portfolio
    • 9.5.3 Business Strategies
    • 9.5.4 SWOT Analysis
    • 9.5.5 Major News and Events

10 Japan Aptamers Market - Industry Analysis

  • 10.1 Drivers, Restraints, and Opportunities
    • 10.1.1 Overview
    • 10.1.2 Drivers
    • 10.1.3 Restraints
    • 10.1.4 Opportunities
  • 10.2 Porters Five Forces Analysis
    • 10.2.1 Overview
    • 10.2.2 Bargaining Power of Buyers
    • 10.2.3 Bargaining Power of Suppliers
    • 10.2.4 Degree of Competition
    • 10.2.5 Threat of New Entrants
    • 10.2.6 Threat of Substitutes
  • 10.3 Value Chain Analysis

11 Appendix